If there is a proposal from the European Commission to amend the EU’s medtech regulation in one way or another, I would personally only expect to see that happen after the new European Commission is formed. And “that is likely to be towards the end of 2024.”
That was the prediction voiced by Oliver Bizazza, CEO of MedTech Europe, during an interview with Medtech Insight on the first day of the recent MedTech Forum, organized by his...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?